Clinical Trial Update: Setmelanotide in a Single Patient With Partial Lipodystrophy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update reporting on a single patient treated with setmelanotide for partial lipodystrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia
• Obesity

Drugs mentioned

• Setmelanotide (setmelanotide)

Snippet

Sponsor: Rhythm Pharmaceuticals, Inc. | Conditions: Hypertriglyceridemia, Obesity | Phase 2 | Status: COMPLETED